Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (March 19, 2002). doi:10.1152/physiolgenomics.00065.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
9/2/85    most recent
00065.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daly, C. J
Right arrow Articles by McGrath, J. C
Right arrow Search for Related Content
PubMed
Right arrow Articles by Daly, C. J
Right arrow Articles by McGrath, J. C

Articles in PresS, published online ahead of print March 19, 2002
Physiol Genomics, 10.1152/physiolgenomics.00065.2001
Submitted on August 7, 2001
Accepted on March 6, 2002

A knockout approach indicates a minor vasoconstrictor role for vascular {alpha}1b-adrenoceptors in mouse

Craig J Daly1*, Clare Deighan1, Ann McGee1, Dawson Mennie1, Zeeshan Ali1, Melissa McBride1, and John C McGrath1

1 Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom

* To whom correspondence should be addressed. E-mail: c.daly{at}bio.gla.ac.uk.

Pharmacological analysis alone has failed to clarify the role of the three {alpha}1-adrenoceptor subtypes in modulating vascular tone, due to a lack of sufficiently selective antagonists, particularly for the {alpha}1B-adrenoceptor, and the complexity when three receptor subtypes are potentially activated by the same agonist. We adopted a combined genetics/pharmacology strategy based on the {alpha}1B-adrenoceptor knockout mouse. The potency of 3 {alpha}1-adrenoceptor antagonists versus phenylephrine was tested in aorta, carotid, mesenteric and caudal isolated arteries from knockout (KO) and wildtype (WT) mice. In the KO mouse the pharmacology became straightforward showing {alpha}1D- in two major conducting arteries (aorta and carotid) and {alpha}1A- in two distributing arteries (mesenteric and caudal). Combining antagonist pharmacology and genetics simplified analysis of {alpha}1 mediated vasoconstriction, demonstrating that {alpha}1D- & {alpha}1A- are the major subtypes involved in vasoconstriction, with a minor but definite contribution from {alpha}1B- in every vessel.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
X. Chen, S. F. Perry, S. Aris-Brosou, C. Selva, and T. W. Moon
Characterization and functional divergence of the {alpha}1-adrenoceptor gene family: insights from rainbow trout (Oncorhynchus mykiss)
Physiol Genomics, December 19, 2007; 32(1): 142 - 153.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Finch and R. M. Graham
The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister
Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity
Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. M. Shafaroudi, M. McBride, C. Deighan, A. Wokoma, J. Macmillan, C. J. Daly, and J. C. McGrath
Two "Knockout" Mouse Models Demonstrate That Aortic Vasodilatation Is Mediated via {alpha}2A-Adrenoceptors Located on the Endothelium
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 804 - 810.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber
Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Chalothorn, H. Zhang, J. A. Clayton, S. A. Thomas, and J. E. Faber
Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H947 - H959.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. J. Daly, I. McGrath, S. Townsend, and D. E. Berkowitz
The Role of the {alpha}1B-Adrenergic Receptor in Vascular Structure and Function
Hypertension, June 1, 2005; 45(6): e20 - e21.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. A. Flavahan
Phenylpropanolamine Constricts Mouse and Human Blood Vessels by Preferentially Activating {alpha}2-Adrenoceptors
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 432 - 439.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hosoda, T.-a. Koshimizu, A. Tanoue, Y. Nasa, R. Oikawa, T. Tomabechi, S. Fukuda, H. Shinoura, S. Oshikawa, S. Takeo, et al.
Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation
Mol. Pharmacol., March 1, 2005; 67(3): 912 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Zhang, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and J. E. Faber
Gene deletion of dopamine {beta}-hydroxylase and {alpha}1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2106 - H2114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hague, M. A. Uberti, Z. Chen, R. A. Hall, and K. P. Minneman
Cell Surface Expression of {alpha}1D-Adrenergic Receptors Is Controlled by Heterodimerization with {alpha}1B-Adrenergic Receptors
J. Biol. Chem., April 9, 2004; 279(15): 15541 - 15549.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. A. Perez-Rivera, G. D. Fink, and J. J. Galligan
Increased Reactivity of Murine Mesenteric Veins to Adrenergic Agonists: Functional Evidence Supporting Increased {alpha}1-Adrenoceptor Reserve in Veins Compared with Arteries
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 350 - 357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.